PIOGLITAZONE
Tracking # 20-1055186
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
PIOGLITAZONE IS A DRUG USED IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PIOGLITAZONE IS THE THIRD MARKETED THIAZOLIDINEDIONE GROUP OF ORAL ANTIDIABETICS, THE FIRST IS TROGLITAZONE WHICH IS NO LONGER AVAILABLE DUE TO HEPATOTOXICITY, AND THE SECOND IS ROSIGLITAZONE, STILL ON THE MARKET. THIS ACTIVITY REVIEWS THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS FOR PIOGLITAZONE IN MANAGING TYPE 2 DIABETES MELLITUS. THIS ACTIVITY HIGHLIGHTS THE MECHANISM OF ACTION, ADVERSE EFFECT PROFILE, MONITORING, AND RELEVANT INTERACTIONS.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I